Recent research focusing on Nexaph peptides, a innovative class of molecules demonstrating considerable promise for affecting multiple disease processes. Distinct from conventional small molecule approaches, these peptides present improved targeting and lesser off-target reactions, making them a truly encouraging pathway for next-generation therape